Immune Responses to Epidermal Growth Factor Receptor (EGFR) and Their Application for Cancer Treatment

por Sasada, Tetsuro, Azuma, Koichi, Ohtake, Junya, Fujimoto, Yuki
Publicado 2016

IL-11 induces differentiation of myeloid-derived suppressor cells through activation of STAT3 signalling pathway

por Sumida, Kentaro, Ohno, Yosuke, Ohtake, Junya, Kaneumi, Shun, Kishikawa, Takuto, Takahashi, Norihiko, Taketomi, Akinobu, Kitamura, Hidemitsu
Publicado 2015

Interleukin‐6/STAT3 signaling as a promising target to improve the efficacy of cancer immunotherapy

por Kitamura, Hidemitsu, Ohno, Yosuke, Toyoshima, Yujiro, Ohtake, Junya, Homma, Shigenori, Kawamura, Hideki, Takahashi, Norihiko, Taketomi, Akinobu
Publicado 2017

Identification of Novel HLA Class II-Restricted Neoantigens Derived from Driver Mutations

por Iiizumi, Susumu, Ohtake, Junya, Murakami, Naoko, Kouro, Taku, Kawahara, Mamoru, Isoda, Fumiko, Hamana, Hiroshi, Kishi, Hiroyuki, Nakamura, Norihiro, Sasada, Tetsuro
Publicado 2019

Randomized, Phase II study of pemetrexed plus bevacizumab versus pemetrexed alone after treatment with cisplatin, pemetrexed, and bevacizumab in advanced non‐squamous, non‐small ce...

por Kasai, Takashi, Mori, Kiyoshi, Nakamura, Yoichi, Seki, Nobuhiko, Ichikawa, Yasuko, Saito, Haruhiro, Kondo, Tetsuro, Nishikawa, Kazuo, Otsu, Satoshi, Bessho, Akihiro, Tanaka, Hiroshi, Yamaguchi, Hiroyuki, Kaburagi, Takayuki, Imai, Hisao, Mori, Keita, Ohtake, Junya, Okamoto, Hiroaki
Publicado 2023